secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-08-28T20:45:18+00:00
Accession:  0001493152-26-040622
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals receives Nasdaq delisting notice for late Q2 Form 10-Q
------------------------------------------------------------------------------

- Nasdaq notice received Aug 28, 2026 for non-compliance with Listing Rule 5250(c)(1) due to delayed Form 10-Q for quarter ended June 30, 2026.
- Company must submit compliance plan by Oct 27, 2026; Nasdaq may grant exception until Feb 22, 2027.
- No immediate delisting; non-compliance indicator broadcast starting approx. Sept 4, 2026.
- Failure to regain compliance would subject common stock to delisting from Nasdaq; stock continues trading on Nasdaq.
- Company intends to file Form 10-Q as soon as practicable; cites completion of accounting firm review procedures as a factor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226040622/0001493152-26-040622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226040622/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer